Clinical Trial Update: Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing linagliptin to placebo in people with type 2 diabetes mellitus who have inadequate glycemic control on metformin plus pioglitazone; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (Tradjenta) (linagliptin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-03-26